Cartesian Therapeutics Inc (RNAC)
26.41
+0.07
(+0.27%)
USD |
NASDAQ |
May 17, 16:00
26.41
0.00 (0.00%)
After-Hours: 16:20
Cartesian Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.367 |
| March 31, 2023 | 0.3546 |
| December 31, 2022 | 0.2799 |
| September 30, 2022 | 0.3073 |
| June 30, 2022 | 0.2893 |
| March 31, 2022 | 0.4616 |
| December 31, 2021 | 1.138 |
| September 30, 2021 | -1.358 |
| June 30, 2021 | -5.974 |
| March 31, 2021 | -1.278 |
| December 31, 2020 | -1.377 |
| September 30, 2020 | -3.331 |
| June 30, 2020 | -1.136 |
| March 31, 2020 | -1.925 |
| Date | Value |
|---|---|
| December 31, 2019 | 2.251 |
| September 30, 2019 | -4.258 |
| June 30, 2019 | 384.79 |
| March 31, 2019 | 1.448 |
| December 31, 2018 | -3.947 |
| September 30, 2018 | 2.130 |
| June 30, 2018 | 0.8743 |
| March 31, 2018 | 0.5081 |
| December 31, 2017 | 0.4061 |
| September 30, 2017 | 0.322 |
| June 30, 2017 | 0.1323 |
| March 31, 2017 | 0.2771 |
| December 31, 2016 | 0.2192 |
| September 30, 2016 | 0.183 |
| June 30, 2016 | 0.1732 |
| March 31, 2016 | 0.8257 |
| December 31, 2015 | -0.1018 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-5.974
Minimum
Jun 2021
384.79
Maximum
Jun 2019
18.48
Average
--
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 325.21M |
| Total Liabilities (Quarterly) | 442.01M |
| Shareholders Equity (Quarterly) | -116.80M |
| Current Ratio | 3.031 |
| Net Debt Paydown Yield | 4.88% |